Debiopharm Group
Investor profile
Debiopharm Group has backed 5 European tech companies across 5 funding rounds between 2013 and 2025, joining rounds totalling €36M. Most active in Software and AI. Data as of Nov 2026.
Deals
5
distinct rounds
Companies
5
backed
Active span
2013–2025
13 yrs
Total round €
€36M
sum of rounds joined
Deals by year
distinct rounds / yearDebiopharm Group — deals by year — interactive chart.
Data table
| Debiopharm Group — deals by year | |
|---|---|
| 2013 | 1 |
| 2017 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
Top sectors
by dealsDebiopharm Group — top sectors — interactive chart.
Data table
| Debiopharm Group — top sectors | |
|---|---|
| Software | 2 |
| AI | 1 |
| Media | 1 |
| Telecom | 1 |
| Fintech | 1 |
| Healthtech | 1 |
| Cybersecurity | 1 |
Stages
by dealsDebiopharm Group — stages — interactive chart.
Data table
| Debiopharm Group — stages | |
|---|---|
| Other | 3 |
| Series A | 1 |
| Series B | 1 |
Countries
by dealsDebiopharm Group — countries — interactive chart.
Data table
| Debiopharm Group — countries | |
|---|---|
| Switzerland | 3 |
| Germany | 2 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| StratifAI | Germany | 1 | €13M |
| Mika | Germany | 1 | €10M |
| BC Platforms | Switzerland | 1 | €9.1M |
| Tune Insight | Switzerland | 1 | €3.2M |
| KeyLemon | Switzerland | 1 | €1.1M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| StratifAI | Other | €13M | 2025-09 |
| Mika | Other | €10M | 2022-05 |
| BC Platforms | Series B | €9.1M | 2017-05 |
| Tune Insight | Other | €3.2M | 2023-09 |
| KeyLemon | Series A | €1.1M | 2013-09 |